InspireMD (NSPR) Change in Acquisitions & Divestments (2022 - 2023)

InspireMD's (NSPR) quarterly Change in Acquisitions & Divestments came in at $6.5 million in Q3 2023, down 35.0% year-on-year from $10.0 million in Q3 2022, and up 30.0% quarter-over-quarter from $5.0 million in Q2 2023.

InspireMD (NSPR) Change in Acquisitions & Divestments (2022 - 2023) Analysis & Trends

InspireMD's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $6.5 million for Q3 2023.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 35.0% year-over-year to $6.5 million in Q3 2023; TTM through Dec 2023 was $18.5 million, a 33.93% decrease from a year earlier, with the FY2023 full-year figure at $18.5 million, down 33.93% from the prior year.
  • Change in Acquisitions & Divestments improved to $6.5 million in Q3 2023 per NSPR's latest filing, from $5.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $10.0 million in Q3 2022 and bottomed at $5.0 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.66 Bn 175.36 Bn 6.27 Bn
2 Stryker 128.55 Bn 125.68 Bn 3.81 Bn
3 Medtronic 108.38 Bn 99.16 Bn 6.41 Bn
4 Boston Scientific 68.11 Bn 66.66 Bn 3.61 Bn
5 Edwards Lifesciences 47.19 Bn 43.52 Bn 1.29 Bn
6 Dexcom 28.54 Bn 27.42 Bn 750.30 Mn
7 GE HealthCare Technologies 28.37 Bn 26.09 Bn 1.98 Bn
8 Smith & Nephew 26.90 Bn 26.33 Bn -
9 Koninklijke Philips 25.53 Bn 22.40 Bn 2.07 Bn
10 InspireMD 46.08 Mn -8.13 Mn 1.18 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 6.50 Mn
Sep 30, 2023 6.50 Mn
Jun 30, 2023 5.00 Mn
Jun 30, 2023 5.00 Mn
Mar 31, 2023 7.00 Mn
Mar 31, 2023 7.00 Mn
Dec 31, 2022 6.00 Mn
Dec 31, 2022 6.00 Mn
Sep 30, 2022 10.00 Mn
Sep 30, 2022 10.00 Mn
Jun 30, 2022 6.00 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 6.00 Mn
Mar 31, 2022 6.00 Mn